Company Overview of Larrea Biosciences Corporation
As of June 24, 2015, Larrea Biosciences Corporation was acquired by Gordian Holdings, Inc. Larrea Biosciences Corporation, through its subsidiary, LarreaRx, Inc., engages in manufacturing, licensing, and distributing green dietary supplements. Its products are derived from the desert shrub, Larrea tridentate. The proprietary extract from this plant include Larreastatin, which is the key ingredient in company’s products comprising dietary supplement capsules, topical lotion, and topical spray. The company sells its products through retail channels, direct marketing channels, and distributors under LarreaRx and Shegoi trade names. It has operations in the United States and Canada. Larrea Biosc...
Houston, TX 77006-4122
Key Executives for Larrea Biosciences Corporation
Larrea Biosciences Corporation does not have any Key Executives recorded.
Larrea Biosciences Corporation Key Developments
SEC Revokes Registration Of Registered Securities Of Larrea Biosciences
Oct 23 13
An Administrative Law Judge has issued an initial decision of default as to Larrea Biosciences Corporation. The Order Instituting Proceedings alleged that the company repeatedly failed to file timely periodic reports while its securities were registered with the Securities and Exchange Commission (SEC or the Commission). SEC finds these allegations to be true as to company and revokes the registration of each class of their registered securities, pursuant to Section 12(j) of the Securities Exchange Act of 1934.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 24, 2015
Most Searched Private Companies
Sponsored Financial Commentaries